Literature DB >> 17894923

Melatonin therapy in fibromyalgia.

Russel J Reiter1, Dario Acuna-Castroviejo, Dun-xian Tan.   

Abstract

Fibromyalgia (FM) is a painful syndrome that is more common in women than in men. Whether FM has an organic basis or whether it is psychosomatic is debated. Of the numerous treatments that have been tried, rarely have any been completely effective in relieving the pain of FM. Preliminary evidence indicates that melatonin, a molecule that is endogenously produced and is available as an over-the-counter supplement, may be effective in treating the pain associated with this syndrome. Although melatonin is commonly known as a sleep aid (sleep/wake problems are common in FM sufferers), it has a variety of other beneficial effects that may account for its potential benefits in the treatment of FM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17894923     DOI: 10.1007/s11916-007-0215-3

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  31 in total

1.  Total antioxidant capacity and the severity of the pain in patients with fibromyalgia.

Authors:  Ozlem Altindag; Hakim Celik
Journal:  Redox Rep       Date:  2006       Impact factor: 4.412

2.  Pregabalin and duloxetine for the treatment of neuropathic pain disorders.

Authors:  William Terneus
Journal:  J Pain Palliat Care Pharmacother       Date:  2007

3.  Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis.

Authors:  Henning Vaerøy; Robert Helle; Øystein Førre; Erik Kåss; Lars Terenius
Journal:  Pain       Date:  1988-01       Impact factor: 6.961

4.  The retinohypothalamic tract originates from a distinct subset of retinal ganglion cells.

Authors:  R Y Moore; J C Speh; J P Card
Journal:  J Comp Neurol       Date:  1995-02-13       Impact factor: 3.215

5.  Melatonin levels in women with fibromyalgia and chronic fatigue syndrome.

Authors:  A Korszun; L Sackett-Lundeen; E Papadopoulos; C Brucksch; L Masterson; N C Engelberg; E Haus; M A Demitrack; L Crofford
Journal:  J Rheumatol       Date:  1999-12       Impact factor: 4.666

Review 6.  Evaluation and management of endocrine dysfunction in fibromyalgia.

Authors:  Rinie Geenen; Johannes W G Jacobs; Johannes W J Bijlsma
Journal:  Rheum Dis Clin North Am       Date:  2002-05       Impact factor: 2.670

Review 7.  Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment.

Authors:  Philip Mease
Journal:  J Rheumatol Suppl       Date:  2005-08

8.  Fibromyalgia--a syndrome associated with decreased nocturnal melatonin secretion.

Authors:  J Wikner; U Hirsch; L Wetterberg; S Röjdmark
Journal:  Clin Endocrinol (Oxf)       Date:  1998-08       Impact factor: 3.478

9.  Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis.

Authors:  I J Russell; H Vaeroy; M Javors; F Nyberg
Journal:  Arthritis Rheum       Date:  1992-05

10.  A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome.

Authors:  R Klein; P A Berg
Journal:  Clin Investig       Date:  1994-07
View more
  8 in total

1.  Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment.

Authors:  Rüdiger Hardeland
Journal:  Aging Dis       Date:  2011-02-10       Impact factor: 6.745

Review 2.  Sleep disorders and fibromyalgia.

Authors:  Suely Roizenblatt; Nilton Salles Rosa Neto; Sergio Tufik
Journal:  Curr Pain Headache Rep       Date:  2011-10

Review 3.  Neuroendocrine dysfunction in fibromyalgia and migraine.

Authors:  Marcelo Moraes Valença; Fabíola Lys Medeiros; Hugo A Martins; Rodrigo Meirelles Massaud; Mario F P Peres
Journal:  Curr Pain Headache Rep       Date:  2009-10

4.  Neurochemical and neuropharmacological aspects of circadian disruptions: an introduction to asynchronization.

Authors:  Jun Kohyama
Journal:  Curr Neuropharmacol       Date:  2011-06       Impact factor: 7.363

Review 5.  Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction.

Authors:  Rüdiger Hardeland
Journal:  ScientificWorldJournal       Date:  2012-05-02

6.  Oral Supplementation of Melatonin Protects against Fibromyalgia-Related Skeletal Muscle Alterations in Reserpine-Induced Myalgia Rats.

Authors:  Gaia Favero; Valentina Trapletti; Francesca Bonomini; Alessandra Stacchiotti; Antonio Lavazza; Luigi Fabrizio Rodella; Rita Rezzani
Journal:  Int J Mol Sci       Date:  2017-06-29       Impact factor: 5.923

7.  Melatonin in antinociception: its therapeutic applications.

Authors:  Venkatramanujam Srinivasan; Edward C Lauterbach; Khek Yu Ho; Dario Acuña-Castroviejo; Rahimah Zakaria; Amnon Brzezinski
Journal:  Curr Neuropharmacol       Date:  2012-06       Impact factor: 7.363

8.  Pain control by melatonin: Physiological and pharmacological effects.

Authors:  Wei-Wei Chen; Xia Zhang; Wen-Juan Huang
Journal:  Exp Ther Med       Date:  2016-08-03       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.